WordNet

plan secretly, usually something illegal; "They plotted the overthrow of the government"
a small area of ground covered by specific vegetation; "a bean plot"; "a cabbage patch"; "a briar patch" (同)plot of land, plot of ground, patch
a secret scheme to do something (especially something underhand or illegal); "they concocted a plot to discredit the governor"; "I saw through his little game from the start" (同)secret plan, game
a chart or map showing the movements or progress of an object
the story that is told in a novel or play or movie etc.; "the characters were well drawn but the plot was banal"
devise the sequence of events in (a literary work or a play, movie, or ballet); "the writer is plotting a new novel"

PrepTutorEJDIC

『小区画の土地』,小地所 / (小説・劇などの)『筋』,プロット / 『蔭謀』,たくらみ / 〈悪事〉‘を'『ひそかに計画する』,たくらむ / (地図・海図などに)…‘を'書き込む;…‘の'図表(図面)を作る / 〈土地〉‘を'区画する《+『out』+『名,』+『名』+『out』》 / (…に対して…の)『陰謀を企てる』,たくらむ《+『against』+『名』+『about』(『toward』)+『名』(do『ing』)

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2013/03/09 08:54:02」(JST)

wiki en

Schild regression analysis, named for Heinz Otto Schild, is a useful tool for studying the effects of agonists and antagonists on the cellular response caused by the receptor or on ligand-receptor binding.

Using a dose-response curve or an equivalent curve with concentration and binding %, it is possible to determine the dose ratio, this is a measure of the potency of a drug; it is obtained by dividing the increased equilibrium constant due to drug inhibition by the equilibrium constant without the drug. A Schild plot is a double logarithmic plot, typically Log(dr-1) as the ordinate and Log[B] as the abscissa. This is because a competitive drug B will have a linear plot with the . These experiments must be carried out on a very wide range (therefore the logarithmic scale) as the mechanisms differ over a large scale, such as at high concentration of drug.

Schild regression for ligand binding

Although most experiments use cellular response as a measure of the effect, the effect is, in essence, a result of the binding kinetics; so, in order to illustrate the mechanism, ligand binding is used. A ligand A will bind to a receptor R according to an equilibrium constant :

Kd=k_-1/k₁

Although the equilibrium constant is more meaningful, texts often mention its inverse, the affinity constant (K_aff = k₁/k_-1): A better binding means an increase of binding affinity.

The equation for simple ligand binding to a single homogeneous receptor is

This is the Hill-Langmuir equation, which is practically the Hill equation (biochemistry) described for the agonist binding. In chemistry, this relationship is called the Langmuir equation, which describes the adsorption of molecules onto sites of a surface (see adsorption).

[R]total is the total number of binding sites, and when the equation is plotted it is the horizontal asymptote to which the plot tends; more binding sites will be occupied as the ligand concentration increases, but there will never be 100% occupancy. The binding affinity is the concentration needed to occupy 50% of the sites; the lower this value is the easier it is for the ligand to occupy the binding site.

The binding of the ligand to the receptor at equilibrium follows the same kinetics as an enzyme at steady-state (Michaelis-Menten equation) without the conversion of the bound substrate to product.

Agonists and antagonists can have various effects on ligand binding. They can change the maximum number of binding sites, the affinity of the ligand to the receptor, both effects together or even more bizarre effects when the system being studied is more intact, such as in tissue samples. (Tissue absorption, densitization, and other non equilibrium steady-state can be a problem.)

A surmountable drug changes the binding affinity:

competitive ligand K'd=Kd (1+[B]/K_b)
cooperative allosteric ligand K'd=Kd (K_B+[B]/(K_B+[B]/α))

A nonsurmountable drug changes the maximum binding:

noncompetitive binding [R]t'=[R]t /(1+[B]/K_b)
irreversible binding

The Schild regression also can reveal if there are more than one type of receptor and it can show if the experiment was done wrong as the system has not reached equilibrium.

Radioligand binding assays

The first radio-receptor assay (RRA) was done in 1970 by Lefkowitz et al., using a radiolabeled hormone to determine the binding affinity for its receptor.^[1]

A radio-receptor assay requires the separation of the bound from the free ligand. This is done by filtration, centrifugation or dialysis.^[2]

A method that does not require separation is the scintillation proximity assay that relies on the fact that β-rays from ³H travel extremely short distances. The receptors are bound to beads coated with a polyhydroxy scintillator. Only the bound ligands to be detected.

Today, the fluorescence method is preferred to radioactive materials due to a much lower cost, lower hazard, and the possibility of multiplexing the reactions in a high-throughput manner. One problem is that fluorescent-labeled ligands have to bear a bulky fluorophore that may cause it to hinder the ligand binding. Therefore, the fluorophore used, the length of the linker, and its position must be carefully selected.

An example is by using FRET, where the ligand's fluorophore transfers its energy to the fluorophore of an antibody raised against the receptor.

Other detection methods such as surface plasmon resonance do not even require fluorophores.

References

Ligand receptor binding: Kenakin T, 1993. Pharmacological analysis of drug-receptor interaction New York: Raven Press

^ Lefkowitz RJ, Roth J, Pastan I (November 1970). "Radioreceptor assay of adrenocorticotropic hormone: new approach to assay of polypeptide hormones in plasma". Science 170 (3958): 633–5. doi:10.1126/science.170.3958.633. PMID 4319388.
^ de Jong LA, Uges DR, Franke JP, Bischoff R (December 2005). "Receptor-ligand binding assays: technologies and applications". J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 829 (1–2): 1–25. doi:10.1016/j.jchromb.2005.10.002. PMID 16253574.

External links

curvefit.com - Dose-response curves in the presence of antagonists, for a clear explanation.

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. システマティックレビューおよびメタアナリシス systematic review and meta analysis
2. 生物統計学および疫学に関する一般用語集 glossary of common biostatistical and epidemiological terms
3. 心不全の病態生理：左心室の圧-容積とその他の血行動態の関係 pathophysiology of heart failure left ventricular pressure volume and other hemodynamic relationships
4. 自動血液分析装置 automated hematology instrumentation
5. フローボリューム曲線 flow volume loops

English Journal

Characterization of an mGluR2/3 Negative Allosteric Modulator in Rodent Models of Depression.

Campo B, Kalinichev M, Lambeng N, Yacoubi ME, Royer-Urios I, Schneider M, Legrand C, Parron D, Girard F, Bessif A, Poli S, Vaugeois JM, Poul EL, Celanire S.SourceAddex Pharma SA , Geneva , Switzerland.
Journal of neurogenetics.J Neurogenet.2011 Dec;25(4):152-66.
Abstract: There is growing evidence suggesting that antagonists of group II metabotropic glutamate receptors (mGluR2/3) exhibit antidepressant-like properties in several preclinical models of depression. However, all those studies have been performed using competitive group II non-selective orthoste
PMID 22091727

Direct pharmacological monitoring of the developmental switch in NMDAR subunit composition using TCN 213, a GluN2A-selective, glycine-dependent antagonist.

McKay S, Griffiths NH, Butters PA, Thubron EB, Hardingham GE, Wyllie DJ.SourceCentre for Integrative Physiology, University of Edinburgh, Hugh Robson Building, George Square, Edinburgh, EH8 9XD UK.
British journal of pharmacology.Br J Pharmacol.2011 Oct 24. doi: 10.1111/j.1476-5381.2011.01748.x. [Epub ahead of print]
Background and purpose. Developmental switches in NMDAR subunit expression have been inferred from studies of GluN2 expression levels, changes in kinetics of glutamatergic synaptic currents and sensitivity of NMDAR-mediated currents to selective GluN2B antagonists. Here we use TCN 213, a novel Gl
PMID 22022974

Japanese Journal

Effects of KP-496, a Novel Dual Antagonist for Leukotriene D4 and Thromboxane A2 Receptors, on Contractions Induced by Various Agonists in the Guinea Pig Trachea

Ishimura Masakazu,Kataoka Sayuri,Suda Masahiro,Maeda Takashi,Hiyama Yoshiyuki
Allergology International 55(4), 403-410, 2006
… Schild plot analyses of the antagonistic activities of KP-496 demonstrated that it is a competitive antagonist for LTD4 and TXA2 receptors with pA2 values of 8.64 and 8.23, respectively. …
NAID 130004476914

麻酔下イヌでのアセチルコリンによる膀胱収縮に対するオキシブチニンの代謝物である 4-ethylamino-2-butynyl(2-cyclohexyl-2-phenyl)glycolate (DEOB) の作用

内田勝幸,中島学,小金井恵 [他],山地健人
日本薬理学雑誌 : FOLIA PHARMACOLOGICA JAPONICA 123(5), 363-371, 2004-05-01
… チルコリンによる膀胱内圧の上昇を用量依存的に抑制した．オキシブチニンも同様な抑制作用を示した．各用量における用量反応曲線から5 cmH2Oの膀胱内圧上昇を引き起こすアセチルコリン濃度を算出した．SchildプロットからDEOBおよびオキシブチニンの傾きを求めたところそれぞれ0.78（95%信頼区間0.45～1.11）および1.49（0.91～2.08）であった．また，アセチルコリンの用量反応曲線を2倍だけ高濃度側に移動させるのに必 …
NAID 10013601826

The β_3-Adrenoceptor-Mediated Relaxation Induced by Dopamine in Guinea Pig Taenia Caecum

AKIMOTO Yurie,HORINOUCHI Takahiro,TANAKA Yoshio,KOIKE Katsuo
日本平滑筋学会機関誌 39(3), 39-45, 2003-06
… M), and Schild plot of the data revealed thepA_2 value of 5.55 and the slope of the regression line was 1.13. …
NAID 110002912868